Patent · US Active

Pyrrolo[1,2-B]pyridazine derivatives

US10875866B2 · kind B2 · utility

3Cited by

41References

6Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Stephen E. Ammann · Redwood City, US
Elizabeth M. Bacon · Burlingame, US
Gediminas Brizgys · Redwood City, US
Elbert Chin · San Mateo, US
Chienhung Chou · Dublin, US
Jeromy J. Cottell · Redwood City, US
Marilyn Ndukwe · Lebanon, US
James G. Taylor · Burlingame, US
Nathan E. Wright · San Diego, US
Zheng-Yu Yang · Chapel Hill, US
Sheila Zipfel · San Mateo, US

Key dates

Filing date	Jul 11, 2019
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Jul 11, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.